Back to Search
Start Over
The impact of infectious disease specialists on antibiotic prescribing in hospitals
- Source :
- Clinical Microbiology and Infection, Clinical Microbiology and Infection, Wiley, 2014, 20 (10), pp.963-972. 〈10.1111/1469-0691.12751〉, Clinical Microbiology and Infection, Elsevier for the European Society of Clinical Microbiology and Infectious Diseases, 2014, 20 (10), pp.963-972. ⟨10.1111/1469-0691.12751⟩
- Publication Year :
- 2014
-
Abstract
- International audience; Given the current bacterial resistance crisis, antimicrobial stewardship programmes are of the utmost importance. We present a narrative review of the impact of infectious disease specialists (IDSs) on the quality and quantity of antibiotic use in acute-care hospitals, and discuss the main factors that could limit the efficacy of IDS recommendations. A total of 31 studies were included in this review, with a wide range of infections, hospital settings, and types of antibiotic prescription. Seven of 31 studies were randomized controlled trials, before/after controlled studies, or before/after uncontrolled studies with interrupted time-series analysis. In almost all studies, IDS intervention was associated with a significant improvement in the appropriateness of antibiotic prescribing as compared with prescriptions without any IDS input, and with decreased antibiotic consumption. Variability in the antibiotic prescribing practices of IDSs, informal (curbside) consultations and the involvement of junior IDSs are among the factors that could have an impact on the efficacy of IDS recommendations and on compliance rates, and deserve further investigation. We also discuss possible drawbacks of IDSs in acute-care hospitals that are rarely reported in the published literature. Overall, IDSs are valuable to antimicrobial stewardship programmes in hospitals, but their impact depends on many human and organizational factors.
- Subjects :
- MESH : Drug Prescriptions
Controlled studies
appropriateness
MESH : Drug Resistance, Bacterial
MESH : Randomized Controlled Trials as Topic
law.invention
0302 clinical medicine
Randomized controlled trial
MESH: Drug Prescriptions
law
Medicine
Antimicrobial stewardship
MESH: Physicians
030212 general & internal medicine
MESH : Anti-Bacterial Agents
Practice Patterns, Physicians'
Randomized Controlled Trials as Topic
0303 health sciences
infectious disease physician
[ SDV.SPEE ] Life Sciences [q-bio]/Santé publique et épidémiologie
General Medicine
Bacterial Infections
MESH: Hospitals
Hospitals
3. Good health
Anti-Bacterial Agents
MESH : Bacterial Infections
MESH : Hospitals
Infectious Diseases
quality
interventional studies
Microbiology (medical)
medicine.medical_specialty
MESH: Bacterial Infections
MESH : Physicians
review
antibiotic stewardship
Drug Prescriptions
Antibiotic prescribing
curbside consultation
03 medical and health sciences
Antibiotic resistance
MESH: Anti-Bacterial Agents
Physicians
MESH: Drug Resistance, Bacterial
Drug Resistance, Bacterial
Humans
Antibiotic use
Medical prescription
Intensive care medicine
MESH: Humans
030306 microbiology
business.industry
MESH : Humans
MESH: Randomized Controlled Trials as Topic
MESH : Practice Patterns, Physicians'
Infectious disease (medical specialty)
Emergency medicine
MESH: Practice Patterns, Physicians'
antimicrobial
[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie
business
Subjects
Details
- ISSN :
- 14690691 and 1198743X
- Volume :
- 20
- Issue :
- 10
- Database :
- OpenAIRE
- Journal :
- Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
- Accession number :
- edsair.doi.dedup.....b3b3212ffd4940c8a27382ad79ca6128